HEALTH● LOWSep 25 · Sep 25, 2026, 9:03 AM
Prime Medicine stock jumps 8% after FDA clears PM647 trial
Seeking Alpha Tech · north america
Prime Medicine's stock jumped after the FDA cleared a trial for its PM647 medicine. This development suggests progress for the company's research and potential future products.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH2h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent WorldHEALTH4h agoPope Leo recovers after lung surgeryNBC NewsHEALTH4h agoThe health of Leo XIV: the Pope advances in his recovery, but uncertainty remains about his visit to South AmericaClarínHEALTH5h agoHealthcare workers protest in virtually every state over pay, shortages and staffingMexico News Daily